GE HealthCare Secures $750 Million Unsecured Term Loan Led by JPMorgan Chase

Reuters12-16
GE HealthCare Secures $750 Million Unsecured Term Loan Led by JPMorgan Chase

GE HealthCare Technologies Inc. has entered into a three-year senior unsecured term loan credit facility totaling $750 million with JPMorgan Chase Bank, N.A. as administrative agent and a group of lenders. The loan will be available in a single borrowing, subject to customary conditions, and will mature three years from the funding date. The agreement includes typical covenants limiting the company's ability to incur liens, undertake certain transactions, and exceed a specified leverage ratio, as well as restrictions on subsidiary indebtedness. This financing is part of a broader funding strategy, which also includes the recent issuance of $1.25 billion in senior notes, to support the company's acquisition of Intelerad Medical Systems.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GE HealthCare Technologies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-319383), on December 15, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment